Delivery Order SPE2DE21D0005-SPE2D625F0C05

Award Date 2/28/25
Potential Completion Date 3/5/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F31DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products headquartered in Canton, Massachusetts. The $1,239.95 delivery order is for the supply of APLIGRAF, a skin substitute product, and does not utilize any set-aside designation. Organogenesis is an established vendor for the DLA and the Department of Veterans Affairs (VA), providing...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F83GA, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer and provider of regenerative medical products. The $1,239.95 fixed-price delivery order contract is for the supply of APLIGRAF, a skin substitute product, to support advanced wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several significant federal Indefinite Delivery...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF medical products. The $1,239.95 fixed-price delivery order falls under a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a Defense agency, for wound care dressings, discs, and other medical materials. Organogenesis has also secured additional federal contracts with the Department of Veterans Affairs...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F0C05
    Delivery Order

This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical and the Department of Veterans Affairs (VA) for the supply of APLIGRAF, a skin substitute product.

The contract has not utilized any set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, including a $25 million single-award IDC for surgical implants, a $30 million multiple-award Federal Supply Schedule contract, and a $49.5 million multiple-award IDC for wound care dressings and medical supplies. These contract vehicles allow Organogenesis to provide a comprehensive range of regenerative medicine products to support medical treatments across military and veteran healthcare programs.

Generated 5/30/25, 9:59 AM